HK85490A - Bromocriptine compositions - Google Patents

Bromocriptine compositions Download PDF

Info

Publication number
HK85490A
HK85490A HK854/90A HK85490A HK85490A HK 85490 A HK85490 A HK 85490A HK 854/90 A HK854/90 A HK 854/90A HK 85490 A HK85490 A HK 85490A HK 85490 A HK85490 A HK 85490A
Authority
HK
Hong Kong
Prior art keywords
pharmaceutically acceptable
bromocriptine
compositions
bromocriptine compositions
bromocriptin
Prior art date
Application number
HK854/90A
Other languages
English (en)
Inventor
Zugar Othmar
Mazer Norman
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK85490A publication Critical patent/HK85490A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK854/90A 1984-02-29 1990-10-18 Bromocriptine compositions HK85490A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848405227A GB8405227D0 (en) 1984-02-29 1984-02-29 Bromocriptine compositions

Publications (1)

Publication Number Publication Date
HK85490A true HK85490A (en) 1990-10-25

Family

ID=10557324

Family Applications (1)

Application Number Title Priority Date Filing Date
HK854/90A HK85490A (en) 1984-02-29 1990-10-18 Bromocriptine compositions

Country Status (26)

Country Link
JP (1) JPS60202812A (enrdf_load_stackoverflow)
AT (1) AT387716B (enrdf_load_stackoverflow)
AU (2) AU586621B2 (enrdf_load_stackoverflow)
BE (1) BE901810A (enrdf_load_stackoverflow)
CA (1) CA1256374A (enrdf_load_stackoverflow)
CH (2) CH666406A5 (enrdf_load_stackoverflow)
DE (1) DE3505743C2 (enrdf_load_stackoverflow)
DK (1) DK175016B1 (enrdf_load_stackoverflow)
ES (1) ES8705223A1 (enrdf_load_stackoverflow)
FR (1) FR2560047B1 (enrdf_load_stackoverflow)
GB (1) GB8405227D0 (enrdf_load_stackoverflow)
GR (1) GR850506B (enrdf_load_stackoverflow)
HK (1) HK85490A (enrdf_load_stackoverflow)
HU (1) HU196121B (enrdf_load_stackoverflow)
IE (1) IE58235B1 (enrdf_load_stackoverflow)
IL (1) IL74459A (enrdf_load_stackoverflow)
IT (1) IT1199948B (enrdf_load_stackoverflow)
LU (1) LU85791A1 (enrdf_load_stackoverflow)
MX (1) MX9203626A (enrdf_load_stackoverflow)
NL (1) NL194231C (enrdf_load_stackoverflow)
NZ (1) NZ211247A (enrdf_load_stackoverflow)
PH (1) PH23266A (enrdf_load_stackoverflow)
PT (1) PT80015B (enrdf_load_stackoverflow)
SE (2) SE8500961L (enrdf_load_stackoverflow)
SG (1) SG69390G (enrdf_load_stackoverflow)
ZA (1) ZA851546B (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin
DE4041563A1 (de) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
JP3987963B2 (ja) * 1993-03-17 2007-10-10 スリーエム カンパニー エステルー，アミド−又はメルカプトエステル−誘導分散促進剤を含むエーロゾル配合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE604564A (enrdf_load_stackoverflow) * 1960-06-06
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
DE2553026A1 (de) * 1974-12-04 1976-06-10 Schlueter Edelfett Neue formulierungen
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
IT1158162B (it) * 1977-12-22 1987-02-18 Sandoz Ag Composizioni farmaceutiche a base di derivati dell'ergolena e dell'ergolina
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system

Also Published As

Publication number Publication date
FR2560047B1 (fr) 1988-01-15
IL74459A (en) 1988-12-30
ATA58085A (de) 1988-08-15
DE3505743A1 (de) 1985-08-29
IT8547703A0 (it) 1985-02-20
IT1199948B (it) 1989-01-05
GB8405227D0 (en) 1984-04-04
DK175016B1 (da) 2004-04-26
IE58235B1 (en) 1993-08-11
GR850506B (enrdf_load_stackoverflow) 1985-06-28
MX9203626A (es) 1992-09-01
LU85791A1 (fr) 1985-12-11
IE850495L (en) 1985-08-29
AU586621B2 (en) 1989-07-20
ES8705223A1 (es) 1987-05-01
CH667009A5 (de) 1988-09-15
PT80015A (pt) 1986-02-10
ZA851546B (en) 1986-10-29
DE3505743C2 (de) 1995-02-16
JPH0448776B2 (enrdf_load_stackoverflow) 1992-08-07
NL8500417A (nl) 1985-09-16
BE901810A (fr) 1985-08-26
AT387716B (de) 1989-03-10
AU3500689A (en) 1989-09-14
DK86785A (da) 1985-08-30
SE8500961L (sv) 1985-08-30
AU618599B2 (en) 1992-01-02
NZ211247A (en) 1989-02-24
NL194231C (nl) 2001-10-02
IL74459A0 (en) 1985-05-31
HUT38254A (en) 1986-05-28
JPS60202812A (ja) 1985-10-14
IT8547703A1 (it) 1986-08-20
DK86785D0 (da) 1985-02-26
SG69390G (en) 1990-10-26
SE462259B (sv) 1990-05-28
SE8500961D0 (sv) 1985-02-27
NL194231B (nl) 2001-06-01
CH666406A5 (de) 1988-07-29
HU196121B (en) 1988-10-28
AU3913685A (en) 1985-09-05
PT80015B (pt) 1987-09-18
FR2560047A1 (fr) 1985-08-30
PH23266A (en) 1989-06-23
ES540807A0 (es) 1987-05-01
CA1256374A (en) 1989-06-27

Similar Documents

Publication Publication Date Title
IE880281L (en) Swellable pellets
AU558331B2 (en) Solid medicament formulations containing nifedipine, and processes for their preparation
AU580076B2 (en) Dental preparation, article and method for storage and delivery thereof
AU2732288A (en) Polyethylene wax, and a process for the preparation thereof
AU2707788A (en) Sustained release pharmaceutical composition
AU7792987A (en) Administration and dosage form for drug active agents, reagents or the like and process for the preparation thereof
CY1764A (en) New drug preparation with controlled release of the active compound, and a method for the manufacture thereof
CA2044398A1 (en) Programmed release oral solid pharmaceutical dosage form
ES2019398B3 (es) Nueva composicion para alimentacion de rumiantes, que contiene una sustancia biologicamente activa y su preparacion.
AU586165B2 (en) Drug release device
ZA874899B (en) Controlled release dosage form comprising acetaminophen,pseudeophedrine and dexbrompheniramine
MY101029A (en) Bromocriptine compositions
AU8096591A (en) Composition for solid pharmaceutical preparations containing active vitamins d3 and process for preparation thereof
AU2653788A (en) Manumycin derivatives, a process for the preparation thereof, and the use thereof
AU4246489A (en) New benzoxazolinone derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
AU1888488A (en) Substituted benzimidazoles, a process for the preparation thereof, pharmaceutical formulations containing them, and theuse thereof
HK85490A (en) Bromocriptine compositions
EP0225565A3 (en) Divisible capsule
IE822062L (en) Human proinsulin formulations
DE3264768D1 (en) Novel heptadecapeptide, a method for its preparation and a pharmaceutical composition containing the same
AU8303687A (en) Composition for administration through a body cavity
AU1487988A (en) Package, for instance for tablets for pharmaceutical use
IL65512A (en) 3-(2-(3-alkyl and alkenyl-4-piperidyl)-ethyl)-indoles,their preparation and pharmaceutical compositions containing them
AU7280387A (en) Method for the preparation of a sustained release pharmaceutical composition and the compostion prepared thereby
AU1092095A (en) Intra-uterine ring for the release of an active agent, such as a hormone, and an introducer

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20050224